Daily Legislative Brief from April 18, 2017
                
                
                  Environment
                  SB 532-Relating to  Public Notification of Pollution
                    On Tuesday, April 18th, SB 532, by Senator Bill Galvano  (R-Bradenton), was read for a third time on the Senate floor and passed unanimously  by a vote of 38 yeas to 0 nays. 
                  This bill will require  companies to notify the Florida Department of Environmental Protection (FDEP)  about the release of any dangerous substance within 24 hours of discovery, and  DEP must then publish a public notice within 24 hours.
                  SB 532 will now go to  the Senate floor to be heard.
                  AIF SUPPORTS the  FDEP's role as the recipient of notifications regarding incidents from the  regulated business community do to their experience, expertise, and ability to  determine potential impacts from any reported incidents.
                 
                
                  Legal & Judicial
                  SB 1398-Relating to  Accessibility of Places of Public Accommodation
                    On Tuesday, April 18th, SB 1398, by Senator Linda Stewart (R-Orlando), was heard before the  Senate Appropriations Subcommittee on General Government and passed unanimously  by a vote of 6 yeas to 0 nays. AIF’s Senior Vice President of State and  Federal Affairs, Brewster Bevis, stood in support of this bill.
                  Congress enacted the  Americans with Disabilities Act (ADA) in 1990 prohibiting discrimination on the  basis of disability in employment, state and local government, public  accommodations, commercial facilities, transportation, and telecommunications.  One of the goals of the ADA is to guarantee that individuals with disabilities  are offered full and equal enjoyment of the goods, services, facilities,  privileges, advantages, or accommodations offered by a place of public  accommodation.
                  However, individuals  with disabilities may sue places of public accommodation including private  businesses for alleged violations of the ADA, a problem that is currently  rampant throughout the state.
                  The bill would:
                  
                    - Create a license type  for ADA experts;
 
                    - Require the Department  of Business and Professional Regulation (DBPR) to establish licensing  requirements and regulation for ADA experts;  
 
                    - Allow ADA experts to  determine if the businesses are compliant with the ADA;  
 
                    - Allow businesses to  hire ADA experts and file ADA expert reports with DBPR;
 
                    - Allow businesses to  file remediation plans with DBPR if they are not in compliance with the ADA;
 
                    - Require DBPR to  establish a public website with a registry of remediation plans and  certifications of conformity; and
 
                    - Require courts to  consider remediation plans to determine if a plaintiff filed a claim in good  faith and whether the plaintiff is entitled to attorney’s fees in lawsuits  involving alleged violations of the ADA.
 
                  
                  
                    SB 1398 will go on to the Senate Committee on Appropriations for its next  hearing.
                  AIF SUPPORTS  legislation that makes filing frivolous lawsuits against Florida’s businesses  more difficult to accomplish.
                 
                
                  Health Care
                  SB 888-Relating to  Prescription Drug Price Transparency
                    On Tuesday, April 18th, SB 888, by Senator Aaron Bean  (R-Jacksonville) was heard in  the Senate Appropriation Subcommittee on Health and Human  Services and unanimously passed. AIF stood in support of this bill.
                  Currently, law  requires MyFloridaRX.com to provide the top 150 most prescribed drugs including  their customary prices by pharmacies. This bill would double that number to 300  and codifies monthly reporting to the Agency for Health Care Administration  (“AHCA”). The goal of HB 589 is to create more transparency in drug pricing,  which in turn will give employers and consumers the ability to make more  informed decisions regarding their health care spending. Prescription drug  costs continue to rise, and become a larger percentage of the overall health  care spend in Florida.
                  SB 888 will now go to  the Senate Committee on Appropriations to be heard.
                  AIF SUPPORTS  transparency in drug pricing as a tool for reducing the cost of health care  coverage on Florida’s employers and employees.